KCT0000678招募中未知
Treatment Strategies and outcomes fo Acute Symptomatic internal Carotid Artery Occlusion in Korea
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- o Limit 至 o Limit（—）
- 性别
- All
入选标准
- •Consecutive patients with ischemic symptomatic internal carotid artery occlusion within 12 hours of symptom onset
排除标准
- •Patients without images work-up for internal carotid artery occlusion were excluded.
研究者
相似试验
已完成
不适用
Outcomes of Treatments for Acute Attack of Primary Angle Closureprimary angle closureJPRN-UMIN000042879Kitasato University109
招募中
不适用
A study of the range of clinical menifestations and future outcome of acute noncompressive myelopathy patients.CTRI/2011/091/000003I30
进行中（未招募）
不适用
Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeks - REAL LIFEEUCTR2005-003485-42-DEycomed GmbH2,000
进行中（未招募）
1 期
Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeksRespuesta al tratamiento en pacientes con síntomas debidos a la enfermedad por reflujo gastroesofágico, con o sin esofagitis, tratados con 40 mg de pantoprazol sódico o.d. durante 8 semanas” - REAL LIFEEUCTR2005-003485-42-ESALTANA Pharma AG2,000
进行中（未招募）
不适用
Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeks - REAL LIFEgastroesophageal reflux diseaseMedDRA version: 8.1Level: lltClassification code 10017885EUCTR2005-003485-42-ATALTANA Pharma AG2,000